Castelli Jeff Insider Trades

Insider Trading History

Track insider trading activity for Castelli Jeff. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$15.9M 1,100,626 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $5.93M 409,311 shares
Last Trade
Jan 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$330k 23,102 shares
$14.27
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $6.27M 432,413 shares
Last Trade
Jan 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$98.5k 6,905 shares
$14.27
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Nov 24, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$452k 50,000 shares
$9.03
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $7.47M 515,476 shares
Last Trade
Nov 24, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$452k 50,000 shares
$9.03
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $6.37M 439,318 shares
Last Trade
Nov 24, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$774k 76,158 shares
$10.16
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $6.74M 465,476 shares
Last Trade
Feb 11, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$217k 22,724 shares
$9.57
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $7.07M 488,200 shares
Last Trade
Feb 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$501k 52,338 shares
$9.57
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $6.32M 435,862 shares
Last Trade
Jan 04, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$29.4k 3,127 shares
$9.41
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $6.57M 453,288 shares
Last Trade
Jan 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.42M 150,517 shares
$9.41
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $6.36M 438,989 shares
Last Trade
Jan 03, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$135k 14,299 shares
$9.41
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $5.36M 370,215 shares
Last Trade
Jan 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$65.1k 6,990 shares
$9.31
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $5.26M 362,800 shares
Last Trade
Jan 09, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$137k 10,005 shares
$13.65
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $5.61M 387,210 shares
Last Trade
Jan 09, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$197k 14,405 shares
$13.65
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $5.47M 377,205 shares
Last Trade
Jan 09, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$137k 10,005 shares
$13.65
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $5.4M 372,805 shares
Last Trade
Jan 04, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$42k 3,127 shares
$13.44
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $5.45M 375,932 shares
Last Trade
Jan 03, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$191k 14,083 shares
$13.53
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $5.77M 398,053 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.41M 99,073 shares
$14.24
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $5.65M 390,015 shares
Last Trade
Jan 02, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$114k 8,038 shares
$14.24
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Development Officer
Holding Value $4.94M 340,661 shares
Last Trade
Dec 28, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$253k 17,421 shares
$14.52
$14.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up